Current Studies


SAS115359, a Safety and Efficacy Study of Inhaled Fluticasone
Propionate/Salmeterol Combination versus Inhaled Fluticasone
Propionate in the Treatment of Adolescent and Adult Subjects with Asthma

Critical Care

A Randomized, Double-blind, Placebo-controlled, Parallel group Safety and Efficacy Study of H.P. Acthar® Gel (Acthar) in Subjects with Acute Respiratory Distress Syndrome (ARDS)

Interventional Pulmonology

Bronchial Sample Collection for a Novel Genomic Test -2
Early Diagnosis of Pulmonary Nodules Using a Plasma Protemic Classifier


Lung Volume Reduction Coil Treatment in Patients with Emphysema (RENEW) Study

HZC113782: A Clinical Outcomes Study to compare the effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg with placebo on Survival in Subjects with moderate Chronic Obstructive Pulmonary Disease (COPD) and a history of or at increased risk for cardiovascular disease

Double-blind, Randomized, Placebo-controlled, Parallel-group, Phase IV Study to Evaluate the Effect of Aclidinium Bromide on Long-term Cardiovascular Safety and COPD Exacerbations in Patients with Moderate to Very Severe COPD (ASCENT COPD)

A 52-week, Double-Blind, Randomized, Placebo Controlled Parallel Group Study to Evaluate the Effect of Roflumilast 500 μg on Exacerbation Rate in Subjects with Chronic Obstructive Pulmonary Disease (COPD) Treated with a Fixed Dose Combination of Long-Acting Beta Agonist and Inhaled Corticosteroid (LABA/ICS)